Yahoo
NYSE - Delayed Quote USD

Humana Inc. (HUM)

401.54 -4.98 (-1.23%)
At close: September 4 at 4:02:45 PM EDT
407.96 +6.42 (+1.60%)
After hours: 8:00:00 PM EDT
Trade Humana on Coinbase
Chart Range Bar
Loading chart for HUM

What's happening with HUM?

59m ago
Powered by Yahoo Scout

Humana (HUM) faces significant challenges with a recent $541.5 million settlement over Medicare overbilling and plans to cut Medicare Advantage plans affecting 600,000 members. Despite these issues, the company is praised for its strong employee culture and potential for growth through improved Star ratings and AI technology.

Powered by Yahoo Scout
  • Previous Close 406.52
  • Open 404.34
  • Bid 386.00 x 30000
  • Ask 410.60 x 10000
  • Day's Range 398.59 - 409.06
  • 52 Week Range 163.11 - 428.88
  • Volume 772,778
  • Avg. Volume 1,360,798
  • Market Cap (intraday) 48.217B
  • Beta (5Y Monthly) 0.75
  • PE Ratio (TTM) 38.46
  • EPS (TTM) 10.44
  • Earnings Date Nov 6, 2026
  • Forward Dividend & Yield 3.54 (0.88%)
  • Ex-Dividend Date Oct 30, 2026
  • 1y Target Est 418.61

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

www.humana.com

67,060

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HUM
57.94%
S&P 500 (^GSPC)
12.75%

1-Year Return

HUM
30.56%
S&P 500 (^GSPC)
18.71%

3-Year Return

HUM
9.60%
S&P 500 (^GSPC)
70.93%

5-Year Return

HUM
1.58%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 40.87B
Earnings 694M
Profit Margin 1.70%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
10B
20B
30B
40B
-2.0%
-1.0%
0.0%
1.0%
2.0%

Analyst Insights

View More

Top Analyst

Guggenheim
58/100
Latest Rating
Buy

Analyst Price Targets

280.00 Low
418.61 Average
401.54 Current
513.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/10/2026
Analyst JP Morgan
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 316 -> 393

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    47.42B

  • Enterprise Value

    54.77B

  • Trailing P/E

    37.32

  • Forward P/E

    25.64

  • PEG Ratio (5yr expected)

    1.32

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    2.47

  • Enterprise Value/Revenue

    0.38

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.88%

  • Return on Assets (ttm)

    3.90%

  • Return on Equity (ttm)

    6.89%

  • Revenue (ttm)

    145.68B

  • Net Income Avi to Common (ttm)

    1.28B

  • Diluted EPS (ttm)

    10.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.87B

  • Total Debt/Equity (mrq)

    76.49%

  • Levered Free Cash Flow (ttm)

    1.94B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

401.54 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • The pressure on the stock market was released a bit on Wednesday, as energy prices only inched higher and Treasury yields across the curve were mostly flat.

    The pressure on the stock market was released a bit on Wednesday, as energy prices only inched higher and Treasury yields across the curve were mostly flat. Both oil and yields have popped higher since August 26. DELL was the star of the day, surging 16% after the company reported a blowout quarter. The stock is very close to breaking out of a three-month consolidation that alleviated an extreme overbought momentum condition on a daily and weekly basis.

  • This should be another wild week for individual stock volatility, which seems like the norm of late.

    This should be another wild week for individual stock volatility, which seems like the norm of late. It will a heavy earnings week for IT once again as, by order of reporting, we have PLTR, TSEM, AMD, ANET, ALAB, LSCC, SHOP, SNDK, WDC, APP, EBAY, HUBS, TTMI, DDOG, NET, TWLO, TEAM, and AKAM all in play. Many Industrial, Healthcare, and Energy stocks also report. And then there is the July employment report, out on Friday morning.

  • Humana Earnings: Merely Affirming 2026 Guidance Tests Shares

    Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

    Rating
    Price Target
  • Argus Quick Note: Weekly Stock List for 07/20/2026: Shooting Stars and Falling Angels in 2Q26

    In the first half of 2026, the S&P 500 popped 9%. The upside was realized in the second quarter, with a gain of 15% after a loss of 4% in 1Q. Driving the market was 29% growth in earnings for S&P 500 companies. Despite the gains, the second quarter saw plenty of challenges. First, oil prices spiked due to the war between Iran and the U.S. and the closure of the Strait of Hormuz. Oil prices in April hit a peak of $113 and were volatile the entire quarter. As well, concerns about the possible overvaluation of stocks tied to AI growth roiled markets. Finally, Wall Street considered the unknown impact of a new Federal Reserve chairman. In the Argus universe of more than 500 public companies, both BUY-rated and HOLD-rated, the average stock increased 11.4%, and the median stock gained 7.2%. The top-10 BUY-rated stocks rose 128% on average. Our list this week features the top-10 performers from the Argus universe during 2Q, and we note that all but one are in the Information Technology (IT) sector. That's no surprise as growth stocks led the 2Q rally, with the IWF growth index up 18%. Still, value was no slacker, with the IWD value index up 15%. We also list the bottom-five performers for 2Q. Why do we study past performance? We like to see which stocks weathered storms, review the mix of sector performance, and see if any new names popped up. The third quarter has started off with a sluggish performance from the IT sector, with ongoing concerns about the AI trade. But that signals that the rally might be set to broaden to other sectors, which could keep the bull run going. Argus expects growth to continue to lead and we do expect positive overall gains in 3Q.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: